评估患者与研究者共同呈现研究结果的两臂平行随机对照试验方案:硬皮病以患者为中心的干预网络-患者与研究者共同参与研究分享(SPIN-PAIRS)试验
本研究为混合方法研究,嵌套两臂平行优效性随机对照试验,比较患者与研究者共同呈现与研究者单独呈现研究结果的效果。主要结局为参会者对信息完整性、可理解性、患者相关性和结果信任度的评分。计划至少需116名受试者以达到80%把握度,于2025年8月开始招募。
要点
- SPIN-PAIRS试验比较患者-研究者共同呈现与研究者单独呈现研究结果的效果。
- 主要结局为参会者对信息完整性、可理解性、患者相关性和结果信任度的0-10分评分。
- 采用线性混合模型比较结局,并进行亚组分析和质性访谈。
核心结论
- 研究结果将有助于构建与研究对象及其他有相关生活经验者分享结果的有效策略证据基础。
研究设计与样本
- 混合方法研究:两臂平行优效性随机对照试验嵌套于以患者为导向的研究活动,并对患者与研究者共同呈现者分别进行访谈及对试验参与者进行访谈。
- 计划至少需要116名参与者以达到80%把握度,但不限制入选人数。
- 参会者按1:1随机分配到虚拟房间,分别观看四段预先录制的患者-研究者共同呈现或四段研究者单独呈现。
- 每段呈现后参会者立即评分,所有结局均采用0-10数字评定量表测量。
主要发现
- 主要结局为活动参会者对呈现的评分:(1)信息完整性,(2)可理解性,(3)对患者的相关性,(4)对结果的信任度。
- 次要目标包括按参与者特征(性别、年龄、种族或族裔、国家、教育水平、健康素养)对主要结局进行亚组分析,以及通过质性访谈更好理解结局评分并为共同呈现提供信息。
- 将使用线性混合模型比较结局,每个结局每位参与者有四次观察(每段呈现一次观察)。
- 访谈将在活动后<2周内进行,逐字转录稿采用归纳-演绎主题分析法分析。
关键数值与推荐
- 符合条件的试验参与者为自报由医生诊断为系统性硬化症(SSc,硬皮病)的18岁及以上成人。
- 参会者不会被告知参与随机试验或两种条件正在比较,且对研究比较和假设设盲;呈现者在活动期间不设盲。
- 活动前,研究者通过公开摘要征集和患者主导的选择委员会选出;研究者预先录制单独呈现,随后接受共同呈现培训并与患者伙伴开发共同呈现并录制。
- 每个虚拟房间在每段呈现后进行现场问答,两臂呈现相同研究。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Researchers are mandated ethically to share study results with participants, and funding agencies emphasize dissemination to others with relevant lived experience. Many researchers, however, find it difficult to communicate study purposes, methods, results, and significance to patients. Our Scleroderma Patient-centered Intervention Network (SPIN) piloted "co-presentation," which involves researchers and patient partners jointly presenting results to other patients. The SPIN Patients Alongside Investigators in Research-Sharing (SPIN-PAIRS) Trial will be conducted as part of a 90-min virtual research event for people with systemic sclerosis (SSc, scleroderma) and will compare patient and researcher partner co-presentation versus researcher-alone presentation. Primary outcomes will be event attendee ratings of presentations on (1) information completeness, (2) understandability, (3) relevance to patients, and (4) trust in findings. Secondary objectives are to (1) conduct subgroup analyses of primary outcomes by participant characteristics (gender, age, race or ethnicity, country, education level, health literacy) and (2) use qualitative interviews to better understand outcome ratings and inform co-presentation. METHODS: This will be a mixed-method study with (1) a two-arm parallel superiority randomized controlled trial embedded in a patient-oriented research event and (2) interviews with patient and researcher co-presenters, separately, and with trial participants. Pre-event, researchers will be selected to present via an open call for abstracts and a patient-led selection committee. To avoid presentation-related biases, pre-event, researchers will record researcher-alone presentations. They will then receive co-presentation training and develop co-presentations with patient partners, which will also be recorded. Eligible trial participants will be adults aged 18 or older who indicate they have been diagnosed with SSc by a physician. We will recruit participants via social media and email lists from our multinational SPIN Cohort and from patient organization partners to attend the event and rate presentations. Participants will be recruited to register for the event beginning in August 2025. Registered participants will be invited to confirm their registration and enroll in the trial on the day of the event. We will require at least 116 participants for ≥ 80% power but will not restrict the number of enrollees. We will randomly assign event attendees 1:1 to virtual rooms with (1) four pre-recorded patient-researcher co-presentations or (2) four pre-recorded researcher-alone presentations. The same studies will be presented in each arm with live questions and answers after each presentation in each virtual room. Attendees will rate each presentation immediately following the presentation. Participants will not be informed that they are part of a randomized trial, or that two conditions are being compared and will be blind to study comparisons and hypotheses. Presenters will not be blinded during the event. We will compare outcomes, all measured via 0-10 numerical rating scales, using linear mixed models with four observations per participant for each outcome (one observation for each presentation). Interviews will be conducted < 2 weeks post-event, and verbatim transcripts will be analyzed using an inductive-deductive thematic approach. DISCUSSION: Findings will contribute to the evidence base on effective strategies for sharing results with study participants and others with relevant lived experience. Trial registration ISRCTN12805381 ( https://www.isrctn.com/ISRCTN12805381 ).
引用
- Nassar EL, Wurz A, Carrier ME, et al. Protocol for a two-arm parallel randomized controlled trial to evaluate patient and researcher co-presentation of research results: the Scleroderma Patient-centered Intervention Network-Patients Alongside Investigators in Research-Sharing (SPIN-PAIRS) trial. Trials. 2025. PMID: 41225532. doi:10.1186/s13063-025-09256-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。